Domainex and Auspherix today announce an expansion of their collaboration to develop new drugs to tackle the growing threat of resistance to antibiotics. The programme has been extended through to 2017.
Tue, 15/09/2015 - 09:00
Mon, 14/09/2015 - 15:30
On November 4th - 6th 2015, SynBioBeta will once again be bringing together the synthetic biology community for the fourth annual SynBioBeta SF 2015 Conference at Mission Bay Conference Center in San Francisco, California.
Wed, 09/09/2015 - 09:00
Riffyn, Inc. announced the upcoming beta launch of its experimental design software for quality and collaboration in life science, chemical and materials R&D.
Mon, 03/08/2015 - 09:00
SynbiCITE funds Prokarium to complete pre-clinical development
Wed, 08/07/2015 - 10:00
Visbion receives Innovate UK Smart Award for synthetic biology
Wed, 01/07/2015 - 09:00
Cambridge Research Biochemicals (CRB) will continue to supply The Medical Research Council (MRC) with custom-synthesised peptides and bespoke polyclonal and monoclonal antibodies for a further 12 months as a valued preferred supplier under a new pricing agreement.
Wed, 01/07/2015 - 08:00
Domainex Ltd, a private drug discovery service company, today announces that it is launching an integrated bioassay service platform, BioassayBuilder.
Tue, 23/06/2015 - 07:00
BioGateway, the new life science network for Kent is launched today at an event being held at Discovery Park in Sandwich. BioGateway aims to become the most complete life science network in Europe serving as the gateway between the UK and the rest of Europe.
Thu, 23/04/2015 - 12:00
Synbiobeta Conference, London, UK, 23rd April 2015 / Sciad Newswire / Desktop Genetics Ltd (www.deskgen.com
Thu, 16/04/2015 - 09:00
London, UK, 16th April 2015 / Sciad Newswire / The third annual SynBioBeta conference returns